One of the most frequent alterations found in HNSCC is the aberrant expression of the epidermal growth factor receptor (EGFR), upstream of the RAS/ERK/MAPK signaling pathway [43,44], which is consequently, deregulated in HNSCC [45,46,47]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.